Dolby Laboratories Inc.

NYSE: DLB · Real-Time Price · USD
72.61
0.08 (0.11%)
At close: Aug 15, 2025, 3:03 PM

Dolby Laboratories Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 28, 2025 Dec 27, 2024 Sep 27, 2024 Jun 28, 2024 Mar 29, 2024 Dec 29, 2023 Sep 29, 2023 Jun 30, 2023 Mar 31, 2023 Dec 30, 2022 Sep 30, 2022 Jul 1, 2022 Apr 1, 2022 Dec 31, 2021 Sep 24, 2021 Jun 25, 2021 Mar 26, 2021 Dec 25, 2020
Net Income
92.23M 68.07M 58.57M 39.66M 98.21M 67.58M 9.91M 16.41M 95.88M 79.45M 27.76M 39.61M 36.52M 80.01M 44.23M 54.56M 76.34M 142.69M
Depreciation & Amortization
24.43M 25.2M n/a 21.21M 20.78M 20.96M 24.26M 24.3M 24.59M 22.36M 22.57M 27.25M 26.36M 27.42M 42.06M 23.3M 25.23M 22.17M
Stock-Based Compensation
30.66M 36.07M n/a 29.34M 28.91M 31.89M 28.2M 29.22M 29.83M 31.24M 26.96M 27.61M 27.7M 32.66M 24.14M 24.84M 24.41M 26.31M
Other Working Capital
21.28M 33.8M -23.57M -105.04M 49.58M -28.26M 11.86M -7.93M -35.59M -24.09M 8.48M 106.67M -26.08M -55.12M -45.5M 62.5M -51.13M -2.86M
Other Non-Cash Items
-9.55M -2.33M 44.24M -5.44M -970K -4.74M 14.05M 4.17M -2.04M -4.42M 976K -2.68M 2.05M 1.51M -4.16M -1.59M -9.58M -5.51M
Deferred Income Tax
3.57M -7.31M -3.6M -11.23M -1.38M -5.4M 3.32M -2.11M -11.29M -8.26M -322K -9.78M -10.36M -9M -10.57M -9.49M -1.55M -15.44M
Change in Working Capital
33.56M -12.92M 16.96M -52.27M 35.85M -101.89M 5.29M 49.13M -32.43M -63.98M -26.64M 90.59M -19.28M -100.94M 14.08M 80.73M -31.39M -88.06M
Operating Cash Flow
174.9M 106.78M 116.17M 21.26M 181.41M 8.41M 85.02M 121.13M 104.54M 56.4M 51.31M 172.61M 63M 31.66M 109.77M 172.35M 83.47M 82.16M
Capital Expenditures
-6.9M -6.78M -7.38M -7.61M -8.92M -6.1M -8.19M -7.41M -7.52M -7.22M -10.71M -11.16M -11.7M -25.88M -11.84M -13.73M -13.36M -15.53M
Cash Acquisitions
n/a -1.36M -9.92M n/a n/a n/a 11.53M 25.7M n/a n/a -36.63M -769K n/a 11.43M n/a n/a n/a n/a
Purchase of Investments
n/a n/a -12.55M -43.51M -68.38M -35.75M -49.88M -42.51M -7.77M -72.79M -63.16M -46.92M -93.08M -113.15M -19.04M -21.62M -12.72M -13.73M
Sales Maturities Of Investments
15.91M n/a 246.5M 43.38M 59.42M 42.48M 38.35M 46.26M 38.88M 108.31M 33.15M 50.7M 21.25M 12.91M 20.41M 21.16M 11.82M 11.39M
Other Investing Acitivies
16.88M n/a -477.96M n/a n/a n/a n/a n/a n/a n/a 36.63M n/a -37.4M -11.43M -4.5M n/a n/a 16.36M
Investing Cash Flow
25.89M -8.14M -261.31M -7.74M -17.87M 633K -19.71M 22.03M 23.59M 28.3M -40.72M -8.16M -120.94M -126.11M -14.96M -14.19M -14.26M -1.5M
Debt Repayment
n/a n/a -5.26M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-36.51M -47.44M -20M -36.37M -26.49M -114.56M -27.52M -26.82M -51.66M -74.41M -222.42M -191.27M -85.71M -67.49M -97.52M -40.56M -71.92M -68.07M
Dividend Paid
-31.83M -31.55M -28.61M -28.7M -28.72M -28.55M -25.82M -25.84M -25.87M -25.87M -24.25M -25.14M -25.4M -25.28M -22.29M -22.31M -22.34M -22.23M
Other Financial Acitivies
-502K -740K -6.96M -4.83M n/a -325K n/a n/a n/a -766K 1.44M n/a n/a -1.44M n/a n/a n/a -7.36M
Financial Cash Flow
-64.87M -57.57M -60.12M -58.4M -44.16M -125.14M -42.8M -36.83M -67.1M -90.09M -242.43M -197.87M -97.42M -72.84M -86.86M -44.88M -74.43M -46.34M
Net Cash Flow
138.69M 33.91M n/a -45.73M 115.7M -109.31M 18.81M 105.74M 61.94M 3.11M -238.89M -41.58M -155.59M -168.6M 5.78M 113.76M -5.93M 39.45M
Free Cash Flow
168M 100M 108.79M 13.65M 172.49M 2.31M 76.83M 113.72M 97.02M 49.18M 40.6M 161.44M 51.3M 5.78M 97.94M 158.62M 70.11M 66.63M